Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | -0.35% | -4.32% | -5.57% |
Jul. 01 | Codexis Sells Fabry, Pompe Disease Compounds to Crosswalk Therapeutics | MT |
May. 30 | Cantor Fitzgerald Starts Codexis With Overweight Rating, $11 Price Target | MT |
- Stock Market
- Equities
- CDXS Stock
- News Codexis, Inc.
- MarketScreener Editorial Features